Cournot Competition Under Yield Uncertainty: The Case of the U.S. Influenza Vaccine Market

References

• Anupindi R., Akella R. Diversification under supply uncertainty. Management Sci. (1993) 39(8):944–963Link, Google Scholar
• Boston Globe, The Flu shot shortage shows system flaws: Fewer companies making vaccines. (2004) October 10Google Scholar
• Brito D. L., Sheshinski E., Intriligator M. D. Externalities and compulsory vaccinations. J. Public Econom. (1991) 45(1):69–90Crossref, Google Scholar
• Brown D. How U.S. got down to two makers of flu vaccine. Washington Post (2004) October 17):A01–A04Google Scholar
• Carr S., Duenyas I., Lovejoy W. Modeling demand and capacity uncertainty under competition. (2005) . Working paper, UCLA Anderson School of Management, Los AngelesGoogle Scholar
• Cournot A.Recherches sur les principes mathématiques de la theorie des richesses (1838) . [N. T. Bacon, trans. 1897. Researches into the Mathematical Principles of the Theory of Wealth, English ed. Macmillan, New York.]Google Scholar
• Creane A. Note on uncertainty and socially excessive entry. Internat. J. Econom. Theory (2006) 3(4):329–334Crossref, Google Scholar
• Dada M., Petruzzi N. C., Schwarz L. B. A newsvendor's procurement problem when suppliers are unreliable. Manufacturing Service Oper. Management (2007) 9(1):9–32Link, Google Scholar
• Danzon P. M., Periera N. S., Tejwani S. S. Vaccine supply: A cross national perspective. Health Affairs (2005) 24(3):706–717Crossref, Google Scholar
• Federgruen A., Yang N. Optimal supply diversification under general supply risks. (2005) . Working paper, Columbia University, New YorkGoogle Scholar
• Forbes Broken eggs. (2004) November 1Google Scholar
• Gerchak Y., Parlar M. Yield variability, cost trade-offs and diversification in the EOQ model. Naval Res. Logist. (1990) 37(3):341–354Crossref, Google Scholar
• Gerdil C. The annual production cycle for influenza vaccine. Vaccine (2002) 21(16):1776–1779Crossref, Google Scholar
• Gottlieb S. Vaccine makers get a shot in the arm. Forbes.com (2004) October 11Google Scholar
• Government Accountability Office Flu vaccine: Supply problems heighten need to ensure access for high-risk people. (2001) . Report to congressional requesters, U.S. Government Accountability Office, Washington, DCGoogle Scholar
• Henig M., Gerchak Y. The structure of periodic review policies in the presence of random yield. Oper. Res. (1990) 38(4):634–643Link, Google Scholar
• Janssen M., Rasmusen E. Bertrand competition under uncertainty. J. Indust. Econom. (2002) 50(1):11–21Crossref, Google Scholar
• Mankiw N. G., Whinston M. D. Free entry and social inefficiency. RAND J. Econom. (1986) 17(1):48–58Crossref, Google Scholar
• National Influenza Vaccine Summit Comments on the status of prebooked influenza vaccine for 2006–2007. (2006) . http://www.ama-assn.org/ama/pub/category/13732.htmlGoogle Scholar
• National Vaccine Advisory Committee Strengthening the supply of routinely recommended vaccines in the United States. (2003) . http://www.hhs.gov/nvpo/bulletins/nvac-vsr.htm#introGoogle Scholar
• Newsweek The flu shot fiasco. (2004) November 1Google Scholar
• New York Times, The With few suppliers of flu shots, shortage was long in making. (2004) October 17Google Scholar
• Nichol K. L. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch. Int. Med. (2001) 161(5):749–759Crossref, Google Scholar
• O'Mara D., Fukuda K., Singleton J. A. Influenza vaccine: Ensuring timely and adequate supply. Infect. Med. (2003) 20(11):548–554Google Scholar
• PowerMed Pandemic influenza and biothreat preparedness: Role of PMED™ DNA vaccines. (2005) . http://www.powermed.comGoogle Scholar
• Quirmbach H. C. R&D: Competition, risk and performance. RAND J. Econom. (1993) 24(2):157–197Crossref, Google Scholar
• Scherer F. M. An industrial organization perspective on the influenza vaccine shortage. Management Decision Econom. (2007) 28(4–5):393–405Crossref, Google Scholar
• Thompson W. W., Shay D. K., Weintraub E., Brammer L., Cox N., Anderson L. J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. J. Amer. Medical Assoc. (2003) 289(2):179–186Crossref, Google Scholar
• Time The flu snafu. (2004) November 1Google Scholar
• U.S. Census Bureau Nation adds 3 million people in last year; Nevada again fastest-growing state. (2004) . http://www.census.gov/Press-Release/www/releases/archives/population/003153.htmlGoogle Scholar
• Vives X.Oligopoly Pricing: Old Ideas and New Tools (1999) (The MIT Press, Cambridge, MA) Google Scholar
• von Weizsäcker C. C. A welfare analysis of barriers to entry. Bell J. Econom. (1980) 11(2):399–420Crossref, Google Scholar
• World Health Organization Influenza vaccines: WHO position paper. Weekly Epidemiological Record (2002) 77(28):230–239Google Scholar
• Williams D. G. The influenza vaccine supply chain: Structure, risk and coordination. (2005) . Unpublished master's thesis, Massachusetts Institute of Technology—Zaragoza International Logistics Program, Cambridge, MAGoogle Scholar
• Yadav P. Value of creating a redistribution network for influenza vaccine in the United States. Fifth Workshop Bus. Aspects of Closed Loop Supply Chains (2005) (Vanderbilt University, Nashville, TN) Google Scholar
• Yano C. A., Lee H. L. Lot sizing with random yields: A review. Oper. Res. (1995) 43(2):311–334Link, Google Scholar